PT1150704E - Melagatran para o tratamento da inflamacao - Google Patents

Melagatran para o tratamento da inflamacao

Info

Publication number
PT1150704E
PT1150704E PT00902232T PT00902232T PT1150704E PT 1150704 E PT1150704 E PT 1150704E PT 00902232 T PT00902232 T PT 00902232T PT 00902232 T PT00902232 T PT 00902232T PT 1150704 E PT1150704 E PT 1150704E
Authority
PT
Portugal
Prior art keywords
melagatran
inflammation
treatment
prodrug
medicament
Prior art date
Application number
PT00902232T
Other languages
English (en)
Inventor
Kirk Ian
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PT1150704E publication Critical patent/PT1150704E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
PT00902232T 1999-01-13 2000-01-13 Melagatran para o tratamento da inflamacao PT1150704E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9900070A SE9900070D0 (sv) 1999-01-13 1999-01-13 New use

Publications (1)

Publication Number Publication Date
PT1150704E true PT1150704E (pt) 2006-06-30

Family

ID=20414074

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00902232T PT1150704E (pt) 1999-01-13 2000-01-13 Melagatran para o tratamento da inflamacao

Country Status (20)

Country Link
US (3) US6683054B1 (pt)
EP (1) EP1150704B1 (pt)
JP (1) JP2002534477A (pt)
KR (1) KR100701539B1 (pt)
CN (1) CN1170592C (pt)
AT (1) ATE319473T1 (pt)
AU (1) AU767077B2 (pt)
BR (1) BR0007452A (pt)
CA (1) CA2356611A1 (pt)
CY (1) CY1107465T1 (pt)
DE (1) DE60026491T2 (pt)
DK (1) DK1150704T3 (pt)
ES (1) ES2257282T3 (pt)
IL (1) IL143985A0 (pt)
NO (1) NO20013414D0 (pt)
NZ (1) NZ512713A (pt)
PT (1) PT1150704E (pt)
SE (1) SE9900070D0 (pt)
WO (1) WO2000041716A1 (pt)
ZA (1) ZA200105275B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9900070D0 (sv) * 1999-01-13 1999-01-13 Astra Ab New use
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
DE10064797A1 (de) * 2000-12-22 2002-06-27 Knoll Ag Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon
SE0101762D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab New use
DE10133786A1 (de) * 2001-07-16 2003-02-06 Boehringer Ingelheim Pharma Verwendung von Thrombin-Inhibitoren zur Behandlung von Arthritis
SE0103590D0 (sv) * 2001-10-26 2001-10-26 Astrazeneca Ab New Combination
SE0200198D0 (sv) * 2002-01-23 2002-01-23 Astrazeneca Ab New use
SE0203349D0 (sv) * 2002-11-12 2002-11-12 Astrazeneca Ab New use
SG10201502484SA (en) 2010-03-30 2015-05-28 Verseon Corp Multisubstituted aromatic compounds as inhibitors of thrombin
MX2015012867A (es) 2013-03-15 2016-06-10 Verseon Corp Compuestos aromaticos multisustituidos como inhibidores de serina proteasa.
AU2014238478B2 (en) 2013-03-15 2018-07-19 Verseon Corporation Halogenopyrazoles as inhibitors of thrombin
CA2960790A1 (en) 2014-09-17 2016-03-24 Verseon Corporation Pyrazolyl-substituted pyridone compounds as serine protease inhibitors
CN107405333A (zh) 2015-02-27 2017-11-28 维颂公司 作为丝氨酸蛋白酶抑制剂的被取代的吡唑化合物
KR20210080347A (ko) 2018-07-13 2021-06-30 베르선 인터내셔널 코포레이션 트롬빈 억제제, 제제, 및 그의 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301916D0 (sv) 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US6042821A (en) * 1995-11-21 2000-03-28 Smithkline Beecham Corporation Method of treating sepsis with chemokines
TWI238827B (en) 1995-12-21 2005-09-01 Astrazeneca Ab Prodrugs of thrombin inhibitors
SE9600216D0 (sv) 1996-01-18 1996-01-18 Hans Arne Hansson Styrning av läkningsprocesser
US5669754A (en) * 1996-04-22 1997-09-23 Advanced Dynamics Corporation Ltd. Method and apparatus for collecting plates
SE9601556D0 (sv) * 1996-04-24 1996-04-24 Astra Ab New pharmaceutical formulation of a thrombin inhibitor for parenteral use
SE9603724D0 (sv) * 1996-10-11 1996-10-11 Astra Ab New pharmaceutical parenteral formulation of a thrombin inhibitor
SE9802974D0 (sv) 1998-09-03 1998-09-03 Astra Ab New crystalline forms
CA2345641A1 (en) 1998-09-28 2000-04-06 Merck & Co., Inc. A method for treating inflammatory diseases by administering a thrombin inhibitor
SE9900070D0 (sv) * 1999-01-13 1999-01-13 Astra Ab New use
AR023510A1 (es) 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.

Also Published As

Publication number Publication date
JP2002534477A (ja) 2002-10-15
CN1341028A (zh) 2002-03-20
DE60026491D1 (de) 2006-05-04
ZA200105275B (en) 2002-09-26
US6683054B1 (en) 2004-01-27
AU767077B2 (en) 2003-10-30
ATE319473T1 (de) 2006-03-15
CA2356611A1 (en) 2000-07-20
NO20013414L (no) 2001-07-10
US20080058303A1 (en) 2008-03-06
BR0007452A (pt) 2001-10-16
KR20010101492A (ko) 2001-11-14
NO20013414D0 (no) 2001-07-10
NZ512713A (en) 2004-10-29
CN1170592C (zh) 2004-10-13
IL143985A0 (en) 2002-04-21
CY1107465T1 (el) 2012-12-19
US20040082518A1 (en) 2004-04-29
WO2000041716A1 (en) 2000-07-20
SE9900070D0 (sv) 1999-01-13
EP1150704B1 (en) 2006-03-08
KR100701539B1 (ko) 2007-03-30
AU2336100A (en) 2000-08-01
ES2257282T3 (es) 2006-08-01
DE60026491T2 (de) 2006-11-02
DK1150704T3 (da) 2006-06-12
EP1150704A1 (en) 2001-11-07

Similar Documents

Publication Publication Date Title
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
CY1105120T1 (el) Η αντιμετωπιση αναπνευστικων νοσων
CZ309247B6 (cs) 40-O-(2-hydroxyethyl)rapamycin pro použití jako jediná účinná látka při léčení solidního nádoru
MY127980A (en) A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
SE0101932D0 (sv) Pharmaceutical combinations
SE9900961D0 (sv) Novel compounds
GB0002336D0 (en) Medicaments
SE9802208D0 (sv) Novel compounds
PL351710A1 (en) Anti−inflammatory therapy for inflammatory mediated infection
ATE360428T1 (de) Analgetisches arzneimittel
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
DK1109560T3 (da) Som AICARFT-inhibitorer anvendelige forbindelser
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
IS6130A (is) Bólgueyðandi meðhöndlun fyrir bólgu tengt smit
SE9802209D0 (sv) Novel compounds
AR034142A1 (es) Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion
NO20032006D0 (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
WO2006026604A3 (en) Methods for promoting wound healing
CY1106129T1 (el) Κιταλοπραμη για την αγωγη της υψηλης πιεσεως του αιματος
SE0300535D0 (sv) Treatment of burns
BR0209578A (pt) Uso de um gatran ou de um derivado farmaceuticamente aceitável do mesmo, método de tratamento de fibrose pulmonar, e, formulação farmacêutica
UA84544C2 (ru) Замещенные фенилсульфонамидные ингибиторы продукции бета-амилоида
SE9900438D0 (sv) The pharmacological use of certian cystine derivatives